One of the biggest stumbling blocks facing pharmacogenomics is getting insurance companies to realize the value of genetic testing and agree to foot the bill. That challenge is at the heart of this article from the San Jose Mercury News.
One of the biggest stumbling blocks facing pharmacogenomics is getting insurance companies to realize the value of genetic testing and agree to foot the bill. That challenge is at the heart of this article from the San Jose Mercury News.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.